LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311 | -16.8% | 5,190 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $374 | +3.6% | 5,190 | +5.7% | 0.00% | 0.0% |
| Q1 2023 | $361 | +10.1% | 4,909 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $328 | -99.9% | 4,909 | -10.6% | 0.00% | -50.0% |
| Q3 2022 | $473,000 | -19.1% | 5,489 | +5.6% | 0.01% | 0.0% |
| Q1 2022 | $585,000 | -27.1% | 5,200 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $803,000 | +43.4% | 5,200 | +29.3% | 0.01% | +40.0% |
| Q3 2021 | $560,000 | +180.0% | 4,021 | +164.4% | 0.01% | +150.0% |
| Q2 2021 | $200,000 | -13.8% | 1,521 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $232,000 | +53.6% | 1,521 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $151,000 | -41.7% | 1,521 | -44.1% | 0.00% | -33.3% |
| Q3 2020 | $259,000 | -26.4% | 2,722 | -13.6% | 0.00% | -25.0% |
| Q2 2020 | $352,000 | +53.7% | 3,150 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $229,000 | -43.7% | 3,150 | -19.2% | 0.00% | -25.0% |
| Q4 2019 | $407,000 | +4.9% | 3,900 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $388,000 | -17.8% | 3,900 | -5.8% | 0.01% | -16.7% |
| Q2 2019 | $472,000 | -34.5% | 4,140 | -27.9% | 0.01% | -33.3% |
| Q1 2019 | $721,000 | -13.4% | 5,740 | -6.5% | 0.01% | -18.2% |
| Q4 2018 | $833,000 | -52.9% | 6,140 | -4.7% | 0.01% | -47.6% |
| Q3 2018 | $1,768,000 | +28.5% | 6,440 | -3.0% | 0.02% | +31.2% |
| Q2 2018 | $1,376,000 | +25.4% | 6,640 | 0.0% | 0.02% | +23.1% |
| Q1 2018 | $1,097,000 | +35.8% | 6,640 | +12.5% | 0.01% | +44.4% |
| Q4 2017 | $808,000 | +0.6% | 5,900 | 0.0% | 0.01% | -10.0% |
| Q3 2017 | $803,000 | +12.2% | 5,900 | 0.0% | 0.01% | +11.1% |
| Q2 2017 | $716,000 | +7.3% | 5,900 | -6.3% | 0.01% | +12.5% |
| Q1 2017 | $667,000 | -6.2% | 6,300 | -10.0% | 0.01% | -11.1% |
| Q4 2016 | $711,000 | -5.8% | 7,000 | -5.4% | 0.01% | -10.0% |
| Q3 2016 | $755,000 | -14.5% | 7,400 | 0.0% | 0.01% | -16.7% |
| Q2 2016 | $883,000 | +11.5% | 7,400 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $792,000 | +4.3% | 7,400 | +5.7% | 0.01% | 0.0% |
| Q4 2015 | $759,000 | +45.4% | 7,000 | +14.8% | 0.01% | +42.9% |
| Q3 2015 | $522,000 | -15.1% | 6,100 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $615,000 | +30.9% | 6,100 | 0.0% | 0.01% | +40.0% |
| Q1 2015 | $470,000 | +44.6% | 6,100 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $325,000 | +13.2% | 6,100 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $287,000 | -24.5% | 6,100 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $380,000 | -15.7% | 6,100 | -9.0% | 0.00% | -20.0% |
| Q1 2014 | $451,000 | +28.1% | 6,700 | 0.0% | 0.01% | +25.0% |
| Q4 2013 | $352,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |